Targeted protein degradation: elements of PROTAC design
SL Paiva, CM Crews - Current opinion in chemical biology, 2019 - Elsevier
Targeted protein degradation using Proteolysis Targeting Chimeras (PROTACs) has
emerged as a novel therapeutic modality in drug discovery. PROTACs mediate the …
emerged as a novel therapeutic modality in drug discovery. PROTACs mediate the …
[引用][C] Targeted protein degradation: elements of PROTAC design
SL Paiva, CM Crews - Current Opinion in Chemical Biology, 2019 - cir.nii.ac.jp
Targeted protein degradation: elements of PROTAC design
SL Paiva, CM Crews - Current opinion in chemical …, 2019 - pubmed.ncbi.nlm.nih.gov
Targeted protein degradation using Proteolysis Targeting Chimeras (PROTACs) has
emerged as a novel therapeutic modality in drug discovery. PROTACs mediate the …
emerged as a novel therapeutic modality in drug discovery. PROTACs mediate the …
[HTML][HTML] Targeted Protein Degradation: Elements of PROTAC Design
SL Paiva, CM Crews - Current opinion in chemical biology, 2019 - ncbi.nlm.nih.gov
Targeted protein degradation using Proteolysis Targeting Chimeras (PROTACs) has
emerged as a novel therapeutic modality in drug discovery. PROTACs mediate the …
emerged as a novel therapeutic modality in drug discovery. PROTACs mediate the …
Targeted protein degradation: elements of PROTAC design.
SL Paiva, CM Crews - Current Opinion in Chemical Biology, 2019 - europepmc.org
Targeted protein degradation using Proteolysis Targeting Chimeras (PROTACs) has
emerged as a novel therapeutic modality in drug discovery. PROTACs mediate the …
emerged as a novel therapeutic modality in drug discovery. PROTACs mediate the …